This year’s most popular Pulmonary Hypertension Association social media posts promoted PH awareness, patient stories, advocacy and community events. We are grateful for our online community and look forward to connecting with you in 2026.

PHA News welcomed 14,767 new subscribers this year and focused on providing quality, timely content to keep you up to date on all things PH. Our top 10 stories covered patient care, PH awareness and oxygen and insurance advocacy.

News

Tonya Gage, who leads PHA’s CTEPH Facebook group, shares her story in the latest issue of Pathlight magazine. The December issue of Pathlight focuses on chronic thromboembolic pulmonary hypertension.

News

Flolan (epoprostenol), the first targeted drug for pulmonary arterial hypertension, was discontinued in November.

Diagnosis & treatment | News

Apply now to take part in PHA's Capitol Hill Day on Monday, March 9, 2026. Advocates will speak to legislators about the challenges of accessing supplemental oxygen and affordable, adequate health insurance coverage. No prior advocacy experience is needed.

Get involved | News

Tiffani Brown and Debbie Kittel, co-leaders of the Ohio State University Support Group, gathered 66 pulmonary hypertension patients, caregivers and health care providers for their inaugural Friendsgiving.

Support